| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/21/2011 | US20110177526 Janus family kinases and identification of immune modulators |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177130 Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/21/2011 | US20110177100 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177043 Method of improving differentiation of chondrogenic progenitor cells |
| 07/21/2011 | US20110177028 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 07/21/2011 | CA2787260A1 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery |
| 07/21/2011 | CA2785970A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/20/2011 | EP2345742A1 RNA sequence-specific mediators of RNA interference |
| 07/20/2011 | EP2345732A1 Methods for intracellular delivery of nucleic acids |
| 07/20/2011 | EP2345731A1 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345428A2 Preparation method of prostate tumor-targeted double-regulated oncolytic adenovirus expressing superantigen gene |
| 07/20/2011 | EP2344674A2 Methods for treating, diagnosing, and monitoring lupus |
| 07/20/2011 | EP2344204A2 Telomerase inhibitors and methods of use thereof |
| 07/20/2011 | EP2114130B1 Animal model for adhd |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | CN102131931A Adaptive molecule for delivery of adenovirus vectors |
| 07/20/2011 | CN102131929A Endogenous short hairpin rna and use of same |
| 07/20/2011 | CN102131926A Transfection agent |
| 07/20/2011 | CN102131923A Production of n-acylated sulphur-containing amino acids with microorganisms having enhanced n-acyltransferase enzymatic activity |
| 07/20/2011 | CN102131526A Vector |
| 07/20/2011 | CN102131525A Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/20/2011 | CN102127593A Test method for restricting Ppif gene expression to lighten renal ischemia-reperfusion injury |
| 07/20/2011 | CN102127539A MicroRNA and methods for inhibiting same |
| 07/20/2011 | CN102125698A Method for establishing mouse transplanting tumor model with normal immunologic function |
| 07/20/2011 | CN101508989B Radiation sensibility tumor-targeted promotor and uses thereof |
| 07/20/2011 | CN101397572B Method for rescuing influenza virus and bidirectional transcription vector special therefor |
| 07/19/2011 | US7982027 Lipid encapsulated interfering RNA |
| 07/19/2011 | US7982025 Fusion proteins of Mycobacterium tuberculosis |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982023 Bag proteins and nucleic acid molecules encoding them |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981870 RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis |
| 07/19/2011 | US7981868 Antisense oligonucleotide chemically modified with a phosphorothioate linkage, a 2'-O-methoxyethyl modified sugar, or 5-methylated cytosine; antiinflammatory agents that reduce mucus production in airways |
| 07/19/2011 | US7981863 Administering platelet derived growth factor, endothelial growth factor or a combination to modulate neural stem cell or neural porgenitor cell activity in vivo to a patient suffering from nerveous system disorder or disease |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981671 Use of triplex structure DNA in transferring nucleotide sequences |
| 07/19/2011 | US7981669 Viral vectors |
| 07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
| 07/19/2011 | US7981446 Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| 07/19/2011 | US7981428 Flu vaccines and methods of use thereof |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981410 Using immunoglobulin specific to viral transport protein associated with budding to prevent and treat viral diseases |
| 07/19/2011 | CA2473218C Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2314663C A composition for providing long term stability to cells for diagnostic testing |
| 07/19/2011 | CA2308584C Targeted liposome gene delivery |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/14/2011 | WO2011085347A2 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
| 07/14/2011 | WO2011085276A2 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer |
| 07/14/2011 | WO2011085271A2 Modulation of angiopoietin-like 3 expression |
| 07/14/2011 | WO2011085081A2 Methods of selecting ms patients for antigen specific therapy |
| 07/14/2011 | WO2011085066A2 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 07/14/2011 | WO2011084694A1 Stabilized stat3 decoy oligonucleotides and uses therefor |
| 07/14/2011 | WO2011084548A2 Methods and compositions for detecting recesssive familial fsgs and uses thereof |
| 07/14/2011 | WO2011084460A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 07/14/2011 | WO2011084455A2 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
| 07/14/2011 | WO2011083881A1 Vaccine for treatment of tautopathy |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083464A2 Methods for use of a specific anti-angiogenic adenoviral agent |
| 07/14/2011 | WO2011082694A1 Targeted delivery slow-release stent of gene pharmaceutical for revascularization |
| 07/14/2011 | WO2011040613A8 Therapeutic agent for tumor |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172143 Method of modulating cell survival and reagents useful for same |
| 07/14/2011 | US20110172120 Compositions and Systems for the Regulation of Genes |
| 07/14/2011 | US20110171733 Bovine Immunodeficiency Virus (BIV) Based Vectors |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171202 Method of treating hearing loss using xiap |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | CA2786535A1 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
| 07/14/2011 | CA2786374A1 Methods for use of a specific anti-angiogenic adenoviral agent |
| 07/14/2011 | CA2786071A1 Modulation of angiopoietin-like 3 expression |
| 07/14/2011 | CA2786056A1 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 07/14/2011 | CA2782366A1 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343311A2 Peptide inhibitors of HK2 and their use |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343080A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2342321A2 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP1543158B1 Regulated aptamer therapeutics |
| 07/13/2011 | EP1442140B1 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | CN102124104A Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase |
| 07/13/2011 | CN102123732A Compositions, methods and kits for eliciting an immune response |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |